Efficacy and safety of inhaled N-acetylcysteine in idiopathic pulmonary fibrosis: A prospective, single-arm study.

Journal: Respiratory investigation
PMID: 27108010

Abstract

BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease with few treatment options. The efficacy of N-acetylcysteine in patients with IPF remains controversial. The aim of this research was to investigate the efficacy of inhaled N-acetylcysteine.

Authors

  • Ryo Okuda
    Department of Respiratory Medicine, Saitama Red Cross Hospital, 8-3-33 Kami-ochiai, Chuo-ku, Saitama 338-8553, Japan. Electronic address: b980013@yahoo.co.jp.
  • Hidekazu Matsushima
    Department of Respiratory Medicine, Saitama Red Cross Hospital, 8-3-33 Kami-ochiai, Chuo-ku, Saitama 338-8553, Japan. Electronic address: himatsushima@sunny.ocn.ne.jp.
  • Tomohiro Oba
    Department of Respiratory Medicine, Saitama Red Cross Hospital, 8-3-33 Kami-ochiai, Chuo-ku, Saitama 338-8553, Japan. Electronic address: obatomohiro@hotmail.co.jp.
  • Rie Kawabe
    Department of Respiratory Medicine, Saitama Red Cross Hospital, 8-3-33 Kami-ochiai, Chuo-ku, Saitama 338-8553, Japan. Electronic address: blackberry_wine1218@yahoo.co.jp.
  • Minako Matsubayashi
    Department of Respiratory Medicine, Saitama Red Cross Hospital, 8-3-33 Kami-ochiai, Chuo-ku, Saitama 338-8553, Japan. Electronic address: mizu_mina@hotmail.com.
  • Masako Amano
    Department of Respiratory Medicine, Saitama Red Cross Hospital, 8-3-33 Kami-ochiai, Chuo-ku, Saitama 338-8553, Japan. Electronic address: skyfield1021@gmail.com.
  • Tomotaka Nishizawa
    Department of Respiratory Medicine, Saitama Red Cross Hospital, 8-3-33 Kami-ochiai, Chuo-ku, Saitama 338-8553, Japan. Electronic address: tn1230bungo@yahoo.co.jp.
  • Koujiro Honda
    Department of Respiratory Medicine, Saitama Red Cross Hospital, 8-3-33 Kami-ochiai, Chuo-ku, Saitama 338-8553, Japan. Electronic address: hondakojiro78@gmail.com.

Keywords

External Resources

Popular Topics
Recent Journals